| Literature DB >> 31218222 |
Dequan Zhang1,2, Xuelian Lu3, Yong Liao2, Zhikuan Xia2, Zhuoying Peng2, Xin Yang2, Rongya Yang2.
Abstract
Trichosporon asahii is the major pathogen causing invasive trichosporonosis. Conventional methods of its detection are time-consuming or costly and often require complex DNA extraction and purification steps, which hinders rapid clinical diagnosis. In this study, we evaluated colony PCR, which directly uses colonies or trace clinical samples as the template for amplification, for rapid detection of T. asahii infection. Four methods, namely, direct colony, freeze-thaw, glass beads, and enzymolysis, were compared to select the best DNA extraction strategy. We subsequently designed and screened species-specific primers targeting the intergenic spacer 1 (IGS1) of the ribosomal DNA of T. asahii and used them to detect mock infection clinical samples. The species-specific colony PCR based on glass beads proved advantageous, with short procedure time (154.8 ± 0.6 min), good sensitivity (detection limit, 102 CFU/mL), and specificity for T. asahii, indicating that this method can be used for the rapid and simple identification of clinical samples of T. asahii infection.Entities:
Year: 2019 PMID: 31218222 PMCID: PMC6537005 DOI: 10.1155/2019/1803278
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Strains used in this study and the specificity evaluation of species-specific primers for detecting T. asahii.
| Organism | Strain |
| |||
|---|---|---|---|---|---|
| TA1 | TA2 | TA3 | TA4 | ||
|
| BZP7001 | + | + | + | + |
|
| BZP7002 | + | + | + | + |
|
| BZP7003 | + | + | + | + |
|
| BZP7004 | + | + | + | + |
|
| BZP7005 | + | + | + | + |
|
| BZP9001 | + | + | + | + |
|
| BZP9002 | + | + | + | + |
|
| CBS2479 | + | + | + | + |
|
| BZP4848 | + | + | + | + |
|
| BZP6108 | + | + | + | + |
|
| BZP6198 | + | + | + | + |
|
| BZP6674 | + | + | + | + |
|
| CBS7137 | + | + | + | + |
|
| CBS8520 | + | + | + | + |
|
| CBS8904 | + | + | + | + |
|
| CBS1896 | − | − | − | − |
|
| CBS2043 | − | − | − | − |
|
| CBS2466 | − | − | − | − |
|
| CBS2481 | − | + | + | − |
|
| CBS2482 | − | + | + | − |
|
| CBS4828 | − | + | + | − |
|
| CBS5585 | − | − | − | − |
|
| CBS6864 | − | − | − | − |
|
| CBS7556 | − | − | − | − |
|
| CBS7625 | − | − | − | − |
|
| CBS8261 | − | + | + | − |
|
| CBS8280 | − | − | − | − |
|
| CBS8641 | − | + | − | − |
|
| CBS9051 | − | − | − | − |
|
| CBS10761 | − | − | − | − |
|
| CMCC(F)C8f | − | − | − | − |
|
| CMCC(F)C2f | − | − | − | − |
|
| CMCC(F)C4f | − | − | − | − |
|
| CMCC(F)T10a | − | − | − | − |
|
| CMCC(F)C4k | − | − | − | − |
|
| ATCC90028 | − | − | − | − |
|
| CMCC(F)D2a | − | − | − | − |
|
| CMCC(F)D2e | − | − | + | − |
|
| CMCC(F)T1h | − | − | − | − |
| | BZP1501 | − | − | − | − |
|
| CMCC(F)T5e | − | − | − | − |
|
| CMCC(F)T17a | − | − | − | − |
|
| CMCC(F)T14a | − | − | − | − |
|
| CMCC(F)D1a | − | − | − | − |
|
| CMCC(F)M2b | − | − | − | − |
|
| CMCC(F)M3h | + | − | − | − |
|
| CMCC(F)A5c | − | − | − | − |
|
| CMCC(F)A1g | + | − | − | − |
|
| CMCC(F)A3a | − | − | − | − |
|
| CMCC(F)A7c | − | − | − | − |
|
| CMCC(F)D6j | + | − | − | − |
|
| CMCC(F)D8i | − | − | − | − |
|
| CMCC(F)D13f | − | − | − | − |
|
| CMCC(F)B33a | − | − | − | − |
|
| CMCC(F)B81c | − | − | − | − |
|
| CMCC(F)B57a | − | − | − | − |
|
| CMCC(F)B38c | − | − | − | − |
| | CMCC(F)B69f | − | − | − | − |
|
| Clinical isolates | − | − | − | − |
|
| Clinical isolates | − | − | − | − |
|
| Clinical isolates | − | − | − | − |
|
| Clinical isolates | − | − | − | − |
|
| Clinical isolates | − | − | − | − |
|
| Clinical isolates | − | − | − | − |
|
| Clinical isolates | − | − | − | − |
|
| Clinical isolates | − | − | − | − |
| | Clinical isolates | − | − | − | − |
| Healthy human DNA | − | − | − | − | |
| Negative control | − | − | − | − | |
ATCC: American type culture collection, Rockville, MD, USA; CBS: Centraalbureau voor Schimmelcultures, Baarn, The Netherlands; CMCC: China Medical Culture Collection, Nanjing, China; BZP: The Military Institute of Injury and Reparation, China.
Primers used in this study.
| Primer Name | Sequence (5′-3′) |
|---|---|
| 26SF | ATCCTTTGCAGACGACTTGA |
| 5SR | AGCTTGACTTCGCAGATCGG |
| TA1F | GTGAATCAAGAACGAAGTATAAGGG |
| TA1R | AGACCTCAGCCTCTGACAGC |
| TA2F | CCTTTTGGACTCTCTATGATTGG |
| TA2R | CCATCCTTCCAACTTGTAGCTT |
| TA3F | TTGGACTCTCTATGATTGGCA |
| TA3R | TCTAGTCCTCAACCGCCCT |
| TA4F | GCGACCTCAGCATCTTAATCA |
| TA4R | CTCTGAGGCCTTGCTCCTGT |
Figure 1The sensitivity of colony PCR detection based on different methods. M: DNA Ladder; 1-7: Suspension of the type strain of T. asahii CBS2479, Concentration followed by 107, 106, 105, 104, 103, 102, 101 CFU/mL; 8: Negative control; 1(a): glass beads; 1(b): freeze-thawing; 1(c): direct colony; 1(d): enzymolysis; 1(e): traditional DNA extraction.
Figure 2The positive rate of trace detection of colony PCR trace detection based on different methods for 15 isolates of Trichosporon asahii. M: DNA Ladder; 1: BZP7001; 2: BZP7002; 3: BZP7003; 4: BZP7004; 5: BZP7005; 6: BZP9001; 7: BZP9002; 8: CBS2479; 9: BZP4848; 10: BZP6108; 11: BZP6198; 12: BZP6674; 13: CBS7137; 14: CBS8520; 15: CBS8904; 16: Negative control; 2(a): glass beads; 2(b): freeze-thawing; 2(c): direct colony; 2(d): enzymolysis; 2(e): traditional DNA extraction.
Sensitivities, positive rate of trace detection, and procedure duration of different colony PCR methods for detecting T. asahii.
| Methods | Sensitivity | Positive rate of trace detection | Procedure duration | |||
|---|---|---|---|---|---|---|
| Pretreatment | PCR | Electrophoresis | Total | |||
| glass beads | 102CFU/mL | 100% (15/15) | 4.8±0.6min | 154.8±0.6min | ||
| freeze-thawing | 102CFU/mL | 73.33% (11/15) | 32.7±1.5min | 182.7±1.5min | ||
| direct colony | 103CFU/mL | 73.33% (11/15) | 1±0.3min | 100min | 50min | 151±0.3min |
| enzymolysis | 103CFU/mL | 93.33% (14/15) | 60.6±0.4min | 210.6±0.4min | ||
| traditional DNA extraction | 103CFU/mL | 53.33% (8/15) | 295.4±7.9min | 445.4±7.9min | ||
Results of colony PCR in clinical samples mimicking infection.
| Sample type | PCR results | |||
|---|---|---|---|---|
| Infectious samples | Noninfectious samples | |||
| No. of samples | No. positive (%) | No. of samples | No. positive (%) | |
| Human, whole blood | 10 | 10 (100) | 10 | 0 (0) |
| Human, bronchoalveolar lavage | 10 | 10 (100) | 10 | 0 (0) |
| Human, urine | 10 | 10 (100) | 10 | 0 (0) |